Vimta Lab may test Rs 120 in next 6 months: SP Tulsian

SP Tulsian of sptulsian.com told CNBC-TV18, "Vimta Lab's Q2 numbers has shown remarkable performance with Rs 34 crore income, operating profit has almost more than doubled from Rs 1.7 crore. Operating profit margin has moved from 6 percent to 11 percent, in fact I see that probably FY14 could get surpassed in FY17. So PAT of about 2.5 crore which has almost doubled resulting into an earnings per share (EPS) of about closer to Re 1 plus, only of quarter which was at Rs 2 for whole of FY15. So I am seeing a dramatic turnaround to happen in this company maybe for FY17 but still going by the next six months, I am taking a target of Rs 120 on the stock."At 13:16 hrs Vimta Labs was quoting at Rs 84, up Rs 5.05, or 6.40 percent. It has touched an intraday high of Rs 88 and an intraday low of Rs 80.